Menú

ISAC
ISAC (Intervencions Sanitàries i Activitats Comunitàries)

Group leader
avatar_investigadors.jpg
Francisco Martín Luján
avatar_grups_recerca.png

Publications

Social and Demographic Determinants of Health: A Descriptive Study on the Impact of Place of Residence and Community Belonging

R. PEDRET-LLABERIA, T. BASORA-GALLISÀ, S. MARTÍNEZ-TORRES, S. RODRÍGUEZ-SOLER, M. PALLEJÀ-MILLÁN, A. BUSCEMI, C. REY-REÑONES and F. MARTÍN-LUJÁN
Healthcare. 2025 May 12; . doi:10.3390/healthcare13101125; PMID:40427962

See more:
Classification rule for ten year MACE Risk in primary care tarragona older adults with type2 diabetes: a CHAID decision-tree analysis

D. SEGUÍ, M. FORCADELL, A. VILA-CÓRCOLES, C. DE DIEGO-CABANES, O. OCHOA-GONDAR, F. LUJAN and E. GRACIA
Bmc Primary Care. 2025 Apr 25; . doi:10.1186/s12875-025-02826-w; PMID:40281435

See more:
Effects of prenatal exposure to multiple heavy metals on infant neurodevelopment: A multi-statistical approach?

X. KOU, M. MILLÁN, J. CANALS, V. MORENO, S. RENZETTI and V. ARIJA
ENVIRONMENTAL POLLUTION. 2025 Feb 15; . doi:10.1016/j.envpol.2025.125647; PMID:39761717

See more:
Effectiveness of Primary COVID-19 Vaccination Against Severe Infection in Pediatrics: A Cohort Study Using Two Linked Data Sources in Spain

B. CASTILLO-CANO, F. RIEFOLO, F. VILLALOBOS, M. MARTÍN-PÉREZ, D. MESSINA, D. BRINK-KWAKKEL, C. BISSACCO, E. SEGUNDO, L. SAIZ, L. LEACHE, E. BARBIERI, T. VAZ, R. GINI, O. KLUNGEL and E. MARTIN-MERINO
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more:
VAC4EU Study to Identify Risk Factors and Characterize The Clinical Course of Myocarditis/ Pericarditis Following mRNA-1273 Vaccination in Four European Countries: First Descriptive Analyses

L. ZWIERS, B. GOODALE, F. VAN DER VELDEN, S. ST LAURENT, D. ESPOSITO, L. ZHU, V. URDANETA, D. MARTIN, M. EMILEBACKER, D. WEIBEL, A. LUPATTELLI, A. DESALEGN, F. VILLALOBOS, C. BISSACCO, J. CARRERAS, A. URCHUEGUÍA-FORNES, E. CORRECHER, C. FRY, D. MORRIS, T. AURELIUS, S. LANE, D. ROY, L. WANG, V. EHRENSTEIN, D. GROBBEE and D. ONG
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more: